Jiangsu Hengrui Medicine
600276.SS
#526
Rank
NZ$81.13 B
Marketcap
NZ$12.22
Share price
-2.86%
Change (1 day)
-1.82%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Quarterly Reports

Thumbnail Jiangsu Hengrui Medicine
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: Chinese

View Quarterly Report